BioCorRx Receives FDA Clearance of Investigational New Drug (IND) Application for BICX104, its Implantable Naltrexone Pellet for the Treatment of Opioid Use Disorder
Stock Information for BioCorRx Inc
Loading
Please wait while we load your information from QuoteMedia.